急性ST段抬高型心肌梗死诊断和治疗指南

[31] Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).[J] Camm A John;Kirchhof Paulus;Lip Gregory Y H;Schotten Ulrich;Savelieva Irene;Ernst Sabine;Van Gelder Isabelle C;Al-Attar Nawwar;Hindricks Gerhard;Prendergast Bernard;Heidbuchel Hein;Alfieri Ottavio;Angelini Annalisa;Atar Dan;Colonna Paolo;De Caterina Raffaele;De Sutter Johan;Goette Andreas;Gorenek Bulent;Heldal Magnus;Hohloser Stefan H;Kolh

[32] Early cardiac catheterization laboratory activation by paramedics for patients with ST-segment elevation myocardial infarction on prehospital 12-lead electrocardiograms.[J] Lee Christopher H;Van Gelder Carin M;Cone David C Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2010,

[33] System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention[J] Christian Juhl Terkelsen;Jacob Thorsted Sørensen;Michael Maeng;Lisette Okkels Jensen;Hans-Henrik Tilsted;Sven Trautner;Werner Vach;Søren Paaske Johnsen;Leif Thuesen;Jens Flensted Lassen JAMA: The Journal of the American Medical Association 2010,

[34] Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis; endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).[J] Lip Gregory Y H;Huber Kurt;Andreotti Felicita;Arnesen Harald;Airaksinen Juhani K;Cuisset Thomas;Kirchhof Paulus;Mar

[35] Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis[J] Jessica L Mega;Sandra L Close;Stephen D Wiviott;Lei Shen;Joseph R Walker;Tabassome Simon;Elliott M Antman;Eugene Braunwald;Marc S Sabatine The Lancet 2010,

[36] Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.[J] Lip Gregory Y H Thrombosis and haemostasis 2010,

[37] Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.[J] Tjandrawidjaja Michael C;Fu Yuling;Westerhout Cynthia M;White Harvey D;Todaro Thomas G;Van de Werf Frans;Mahaffey Kenneth W;Wagner Galen S;Granger Christopher B;Armstrong Paul W European heart journal 2010,

[38] Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.[J] Bassand Jean-Pierre;Afzal Rizwan;Eikelboom John;Wallentin Lars;Peters Ron;Budaj Andrzej;Fox Keith A A;Joyner Campbell D;Chrolavicius Susan;Granger Christopher B;Mehta Shamir;Yusuf Salim European heart journal 2010,

[39] Risk of bleeding with single; dual; or triple therapy with warfarin; aspirin; and clopidogrel in patients with atrial fibrillation.[J] Hansen ML;Sorensen R;Clausen MT;Fog Petersen ML;Raunso J;Gadsboll N;Gislason GH;Folke F;Andersen SS;Schramm TK;Abildstrom SZ;Poulsen HE;Kober L;Torp Pedersen C Archives of Internal Medicine 2010,

[40] Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.[J] Cheng Jin M;den Uil Corstiaan A;Hoeks Sanne E;van der Ent Martin;Jewbali Lucia S D;van Domburg Ron T;Serruys Patrick W European heart journal 2009,

[31] Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).[J] Camm A John;Kirchhof Paulus;Lip Gregory Y H;Schotten Ulrich;Savelieva Irene;Ernst Sabine;Van Gelder Isabelle C;Al-Attar Nawwar;Hindricks Gerhard;Prendergast Bernard;Heidbuchel Hein;Alfieri Ottavio;Angelini Annalisa;Atar Dan;Colonna Paolo;De Caterina Raffaele;De Sutter Johan;Goette Andreas;Gorenek Bulent;Heldal Magnus;Hohloser Stefan H;Kolh

[32] Early cardiac catheterization laboratory activation by paramedics for patients with ST-segment elevation myocardial infarction on prehospital 12-lead electrocardiograms.[J] Lee Christopher H;Van Gelder Carin M;Cone David C Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2010,

[33] System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention[J] Christian Juhl Terkelsen;Jacob Thorsted Sørensen;Michael Maeng;Lisette Okkels Jensen;Hans-Henrik Tilsted;Sven Trautner;Werner Vach;Søren Paaske Johnsen;Leif Thuesen;Jens Flensted Lassen JAMA: The Journal of the American Medical Association 2010,

[34] Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis; endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).[J] Lip Gregory Y H;Huber Kurt;Andreotti Felicita;Arnesen Harald;Airaksinen Juhani K;Cuisset Thomas;Kirchhof Paulus;Mar

[35] Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis[J] Jessica L Mega;Sandra L Close;Stephen D Wiviott;Lei Shen;Joseph R Walker;Tabassome Simon;Elliott M Antman;Eugene Braunwald;Marc S Sabatine The Lancet 2010,

[36] Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.[J] Lip Gregory Y H Thrombosis and haemostasis 2010,

[37] Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.[J] Tjandrawidjaja Michael C;Fu Yuling;Westerhout Cynthia M;White Harvey D;Todaro Thomas G;Van de Werf Frans;Mahaffey Kenneth W;Wagner Galen S;Granger Christopher B;Armstrong Paul W European heart journal 2010,

[38] Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes.[J] Bassand Jean-Pierre;Afzal Rizwan;Eikelboom John;Wallentin Lars;Peters Ron;Budaj Andrzej;Fox Keith A A;Joyner Campbell D;Chrolavicius Susan;Granger Christopher B;Mehta Shamir;Yusuf Salim European heart journal 2010,

[39] Risk of bleeding with single; dual; or triple therapy with warfarin; aspirin; and clopidogrel in patients with atrial fibrillation.[J] Hansen ML;Sorensen R;Clausen MT;Fog Petersen ML;Raunso J;Gadsboll N;Gislason GH;Folke F;Andersen SS;Schramm TK;Abildstrom SZ;Poulsen HE;Kober L;Torp Pedersen C Archives of Internal Medicine 2010,

[40] Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.[J] Cheng Jin M;den Uil Corstiaan A;Hoeks Sanne E;van der Ent Martin;Jewbali Lucia S D;van Domburg Ron T;Serruys Patrick W European heart journal 2009,